Innovation in diabetes prevention research: The 36-year legacy of China Da Qing diabetes prevention study
Author:
Publisher
Science China Press., Co. Ltd.
Subject
Multidisciplinary
Link
https://engine.scichina.com/doi/pdf/69CE71683F6D4F3E8248A71FE841DC56
Reference54 articles.
1. Ong K L, Stafford L K, McLaughlin S A. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. Lancet, 2023, 402: 203-234.
2. Rooney M R, Fang M, Ogurtsova K. Global prevalence of prediabetes. Diabetes Care, 2023, 46: 1388-1394.
3. Wang L, Peng W, Zhao Z. Prevalence and treatment of diabetes in China, 2013–2018. JAMA, 2021, 326: 2498-2506.
4. Liu J, Liu M, Chai Z. Projected rapid growth in diabetes disease burden and economic burden in China: A spatio-temporal study from 2020 to 2030. Lancet Regional Health-Western Pac, 2023, 33:
5. Pan X R, Li G W, Hu Y H. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and diabetes study. Diabetes Care, 1997, 20: 537-544.
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3